Charles Robb
Overview
Charles Robb received an average of $3M in total compensation, including $466K in salary, at Corcept Therapeutics from 2017 to 2021.
2021Corcept TherapeuticsChief Business Officer and Secretary
2020Corcept TherapeuticsChief Business Officer and Secretary
2019Corcept TherapeuticsChief Financial Officer and Secretary
2018Corcept TherapeuticsChief Financial Officer and Secretary
2017Corcept TherapeuticsChief Financial Officer and Secretary
Source: SEC filings on April 25, 2022, April 22, 2021, and April 27, 2020.
Related executives
We found 12 more executives who work or worked at Corcept Therapeutics.
Joseph Belanoff
Corcept Therapeutics
Chief Executive Officer
Atabak Mokari
Corcept Therapeutics
Chief Financial Officer
Sean Maduck
Corcept Therapeutics
Chief Commercial Officer
Hazel Hunt
Corcept Therapeutics
Chief Scientific Officer
Andreas Grauer
Corcept Therapeutics
Chief Medical Officer
G Robb
Corcept Therapeutics
Chief Financial Officer
Robert Fishman
Corcept Therapeutics
Chief Medical Officer
Steven Lo
Corcept Therapeutics
Former Senior Vice President, Oncology
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019